Daiwa Securities Group Inc.
Broker-DealerPosition in ABCL — AbCellera Biologics Inc.
CIK 1481045
CHIYODA-KU,TOKYO, M0
Position in ABCL
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,445,275
+$2,441,339 QoQ
Shares Held
311,500
+26963.4% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 150 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Derivatives in ABCL
reported options exposure · as of Jun 30, 2026CallValue
$1,962,500
CallShares
250,000
PutValue
$4,407,775
PutShares
561,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Daiwa Securities Group Inc. holds $185,148,964 across 28 Biotechnology names. ABCL ranks #10 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
749,033 | $41,998,280 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,166,320 | $41,276,064 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
71,534 | $35,533,083 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,643 | $24,095,455 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,904 | $7,797,881 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
22,169 | $4,151,810 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
16,500 | $3,976,005 | |
| 8 | INCY |
Incyte Corp
|
32,675 | $3,704,037 |
All Filings in ABCL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,407,775 | 561,500 | Put | Defined | 2026-07-31 | |
| 2026-06-30 | $2,445,275 | 311,500 | Shares | Defined | 2026-07-31 | |
| 2026-06-30 | $1,962,500 | 250,000 | Call | Defined | 2026-07-31 | |
| 2025-12-31 | $3,936 | 1,151 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,789 | 1,151 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,947 | 1,151 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3 | 1,151 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3 | 1,151 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,992 | 1,151 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3 | 1,151 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $5,214 | 1,151 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $6,572 | 1,151 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $5,294 | 1,151 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $7,435 | 1,151 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $8,678 | 1,151 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $11,659 | 1,151 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $10,483 | 1,060 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $11,289 | 1,060 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $8,014 | 822 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $11,754 | 822 | Shares | Sole | 2022-02-03 | |
| No filing history on record for this holder in this stock. | ||||||